Medicinal – Page 111

Clinical characterization of immunocompetent patients with Scedosporium detected in respiratory samples: A case series

mycolabadmin

This study examined eight elderly patients without compromised immune systems who had the fungus Scedosporium detected in their lungs. All patients had a condition called bronchiectasis, and most had previously suffered from MAC disease. The researchers found that in most cases, the fungus was just colonizing the lungs without causing active infection. The challenge for doctors is determining whether Scedosporium is simply living in the lungs or actively causing disease.

Mycosynthesis of Metal-Containing Nanoparticles—Synthesis by Ascomycetes and Basidiomycetes and Their Application

mycolabadmin

Scientists have discovered that common fungi like mushrooms and molds can produce tiny nanoparticles that fight bacteria, kill cancer cells, and speed up chemical reactions. This fungal method is much cheaper, safer, and more environmentally friendly than traditional chemical production methods. The nanoparticles can be used in medical treatments, wound dressings, water purification, and farming as natural fertilizers and pesticides.

Diversity and bioprospecting activities of endophytic Fungi associated with different Egyptian medicinal plants

mycolabadmin

Scientists studied fungi that live inside Egyptian medicinal plants and found that one type called Aspergillus terreus produces compounds with powerful healing properties. These compounds can fight harmful bacteria, reduce oxidative damage, and even kill cancer cells while being safe for normal cells. This discovery suggests that fungi living in medicinal plants could be valuable sources of new medicines, offering hope for developing new treatments for infections and cancer.

Evidence-Based Nutraceuticals Derived from Antrodia cinnamomea

mycolabadmin

Antrodia cinnamomea, a mushroom from Taiwan traditionally used for health, contains many beneficial compounds that fight inflammation, tumors, and oxidative stress. Research shows it can help with cancer, liver disease, diabetes, and high blood pressure. The mushroom can be grown in laboratories and its active compounds extracted using various modern techniques, making it promising for health supplements and medicines.

The First Report on Agarwood Formation of Aquilaria sinensis (Lour.) Spreng Induced by Fusarium equiseti

mycolabadmin

Researchers successfully induced agarwood (a valuable medicinal resin) formation in Chinese agar trees using a fungus called Fusarium equiseti. Through careful analysis, they found the fungus triggered production of beneficial compounds like agarotetrol and aromatic sesquiterpenes within 12 months, matching quality standards for medicinal use. This breakthrough offers a sustainable alternative to harvesting rare wild agarwood, potentially helping both human health and forest conservation.

RttA, a Zn2-Cys6 transcription factor in Aspergillus fumigatus, contributes to azole resistance

mycolabadmin

Researchers discovered that a fungal protein called RttA plays a key role in helping Aspergillus fumigatus resist azole antifungal drugs. By studying mutant strains, they found that RttA acts as a master switch controlling genes that reduce the effectiveness of antifungal medications. This finding is important because it could help develop new strategies to treat fungal infections that are becoming resistant to current medications.

Selenoproteins in Health

mycolabadmin

Selenium is an essential nutrient that your body needs for healthy immune function, protection against oxidative stress, and proper thyroid function. While you can get selenium from foods like grains, vegetables, nuts, and animal products, the amount available depends on soil selenium levels in the regions where food is grown. Organic forms of selenium from food sources are more effective and safer than inorganic supplements, providing better protection against diseases like cancer, diabetes, and cardiovascular conditions.

Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin Compounds

mycolabadmin

Scientists extracted and analyzed psilocybin and psilocin from Psilocybe cubensis mushrooms to develop a medication for treating mental health disorders like depression and anxiety. Using various analytical techniques, they confirmed the extract contained about 3.26% psilocybin and was safe, pure, and stable. The research shows that creating a psilocybin-based medicine from these mushrooms is feasible and could offer a new treatment option for people struggling with mental health issues.

Disseminated Scedosporium boydii infection with pulmonary and cerebral involvement in a patient with COPD: A case report

mycolabadmin

A 51-year-old man with chronic lung disease developed a life-threatening brain infection caused by a rare fungus called Scedosporium boydii. The infection started in his lungs and spread to his brain, causing a fluid-filled abscess. Despite treatment with antifungal medications and surgery, the patient died because the initial treatment was incomplete and the infection had time to progress to his brain.

Awareness and perception of invasive fungal diseases among the Nigerian population

mycolabadmin

This study found that very few Nigerians (only about 19%) are aware of serious fungal infections like candidiasis and aspergillosis, and most people don’t understand how dangerous these diseases can be. The researchers surveyed over 1,200 people and discovered that people with more education and higher incomes were more likely to know about these infections. The findings suggest that Nigeria urgently needs public health campaigns and education programs to help people recognize fungal diseases early so they can get proper treatment.

Research Topic: Medicinal